Abivax S.A. (ABVX) — Financial statements
Income statement, balance sheet, and cash flow for Abivax S.A. — annual and quarterly history with growth and margin analysis.
| Metric (EUR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00↓100.0% | 11↑133.5% | 5↑0.8% | 5↑12286.5% | 0.04 | |
| Cost of Revenue | 1 | 0.00 | 0.00↓100.0% | 0.11↓29.5% | 0.16 | |
| Gross Profit | -1↓109.5% | 11↑135.9% | 5↑2.3% | 4↑3858.8% | -0.12 | |
| Operating Expenses | ||||||
| R&D Expenses | 171↑16.5% | 147↑42.0% | 103↑111.8% | 49↑2.0% | 48 | |
| General & Administrative Expenses | 0.00↓100.0% | 33↑17.2% | 28↑275.2% | 7↑34.3% | 6 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 6↑739.8% | 0.71 | 0.00 | 0.00 | |
| SG&A Expenses | 69↑77.3% | 39↑35.0% | 29↑284.6% | 7↑34.3% | 6 | |
| Other Expenses | 0.00↑100.0% | -2↓3423.4% | -0.05 | 0.00↑100.0% | -12 | |
| Operating Expenses | 240↑30.4% | 184↑44.3% | 127↑125.3% | 57↑32.7% | 43 | |
| Total Costs & Expenses | 241↑31.0% | 184↑39.3% | 132↑132.9% | 57↑33.0% | 43 | |
| Operating Results | ||||||
| Operating Income | -241↓39.2% | -173↓35.8% | -127↓96.5% | -65↓56.6% | -41 | |
| Depreciation & Amortization | 1↓6.4% | 1↑55.6% | 0.71↑45.8% | 0.49↑210.9% | 0.16 | |
| EBITDA | -240↓39.5% | -172↓29.0% | -133↓149.8% | -53↓38.2% | -39 | |
| EBIT | -241↓39.2% | -173↓29.2% | -134↓148.9% | -54↓38.3% | -39 | |
| Interest & Other Income | ||||||
| Net Interest Income | -22↓425.8% | -4↑63.3% | -11↓64.4% | -7↓99.7% | -3 | |
| Interest Income | 5 | 0.00↓100.0% | 3 | 0.00↓100.0% | 0.08 | |
| Interest Expense | 27↑554.4% | 4↓69.7% | 14↑99.2% | 7↑95.1% | 4 | |
| Non-Operating Income | 0.00↑100.0% | -0.00↓100.0% | 7↑148.0% | -14↓444.0% | -3 | |
| Other Income / Expenses | -79↓2337.9% | -3↑84.0% | -20↓597.2% | 4↑489.4% | -1 | |
| Income Before Tax | -320↓81.7% | -176↓15.8% | -152↓104.8% | -74↓75.1% | -42 | |
| Income Tax Expense | 3 | 0.00↑100.0% | -4↓0.4% | -4 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -323↓83.2% | -176↓19.3% | -148↓143.2% | -61↓43.1% | -42 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -323↓83.2% | -176↓19.3% | -148↓143.2% | -61↓43.1% | -42 | |
| Bottom-Line Net Income | -323↓83.2% | -176↓19.3% | -148↓143.2% | -61↓43.1% | -42 | |
| EPS (Basic) | -4.65↓66.1% | -2.80↑18.4% | -3.43↓7.9% | -3.18↓15.6% | -2.75 | |
| EPS (Diluted) | -4.65↓66.1% | -2.80↑18.4% | -3.43↓7.9% | -3.18↓15.6% | -2.75 | |
| Weighted Average Shares | 70↑10.3% | 63↑46.4% | 43↑125.6% | 19↑23.5% | 15 | |
| Weighted Average Diluted Shares | 70↑10.3% | 63↑46.4% | 43↑125.6% | 19↑23.5% | 15 | |
* All figures in Millions of EUR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.